GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.330
-0.001 (-0.30%)
At close: Jun 26, 2026, 4:00 PM EDT
0.320
-0.010 (-3.03%)
After-hours: Jun 26, 2026, 7:56 PM EDT
GlucoTrack Employees
GlucoTrack had 15 employees as of December 31, 2025. The number of employees increased by 4 or 36.36% compared to the previous year.
Employees
15
Change (1Y)
4
Growth (1Y)
36.36%
Revenue / Employee
n/a
Profits / Employee
-$1,125,933
Market Cap
2.07M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 339 |
| Jin Medical International | 273 |
| Retractable Technologies | 201 |
| Bionano Genomics | 97 |
| Femasys | 54 |
| Nephros | 36 |
| NEXGEL | 19 |
| Milestone Scientific | 15 |
GCTK News
- 11 days ago - GlucoTrack Proxy statement: Proxy filing - Filings
- 4 weeks ago - Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association's 2026 Scientific Sessions - GlobeNewsWire
- 6 weeks ago - Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 6 weeks ago - GlucoTrack Quarterly report: Q1 2026 - Filings
- 6 weeks ago - GlucoTrack Earnings release: Q1 2026 - Filings
- 7 weeks ago - GlucoTrack submits IDE application to initiate study for CBGM technology - TheFly
- 7 weeks ago - Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology - GlobeNewsWire
- 7 weeks ago - GlucoTrack Slides: Investor presentation - Filings